CAR T Cells Target TNF in Mouse Model of Rheumatoid Arthritis
June 30, 2026
A single infusion of engineered T cells degraded soluble TNF and produced durable disease control in mice
2 min read
False
Advertisement
Cell & Gene
Why Early QC Planning Matters in Cell and Gene Therapy
By Laurent Claisse
June 30, 2026
Late-stage CMC setbacks often begin with early QC decisions that shape cell and gene therapy timelines, costs, and regulatory outcomes
7 min read
Cell & Gene
Development & Clinical
Outsourcing
Regulation & Standards
Business & Trends
Technology & Manufacturing
Roving Reporter Asks: What Are Recent Breakthroughs Telling Us About the CGT Field’s Maturity?
June 25, 2026
IBTV speaks with industry leaders at ARM’s Meeting on the Med 2026 to explore what recent clinical, regulatory, and commercial milestones reveal about the next phase of cell and gene therapy
This Week’s CGT News: Gene Therapy Extends Health Span in Mice
June 23, 2026
A gene therapy preserves organ function and boosts life expectancy in mice, while base editing avoids some CRISPR damage in human embryos, and immune clues emerge for CAR T in glioblastoma
4 min read
In Vivo CRISPR Therapy Succeeds in Phase 3 Trial
June 22, 2026
A single infusion of Intellia’s in vivo gene-editing therapy reduced monthly hereditary angioedema attacks by 87 percent
3 min read
Collaboration is the Key to Democratizing Advanced Therapies
By Aaron Dulgar-Tulloch
June 17, 2026
Why no single player can solve the scalability challenge alone
4 min read
Tissue-Resident NK Cells Slow Solid Tumor Growth in Mice
June 16, 2026
The study points to a possible off-the-shelf cell therapy for solid tumors
2 min read
Stem Cells More Cost-Effective than Gene Therapy for Sickle Cell Disease
June 16, 2026
Researchers found gene therapy produced the highest modeled health benefit, but haploidentical stem cell transplantation offered better value at current prices
2 min read
The Scalability Challenge in MSC Therapies
June 12, 2026
John Yoshi Shyu on why mesenchymal stem cell programs stall – and how early manufacturing decisions can determine clinical and commercial success
4 min read
